C01.1 - Award NOTE - Q0637 - Rx Losartan - 770.docx
DOCX document 56 KB Posted
- Solicitation number
- 36C77020Q0637
About this file
This document is an award notice for a federal contract opportunity with the Department of Veterans Affairs for losartan potassium. The contract was awarded to XLCARE Pharmaceuticals Inc. for an undisclosed amount on August 10, 2020 under solicitation number 36C77020Q0637. The award is for losartan 100mg tablets to be supplied to seven VA facilities through the CMOP National Consolidated RX program. Individual award values were not disclosed due to confidentiality of unit pricing. The notice states that another request for quotation will be issued within months for recurring open market pharmaceutical contracts. Contact information is provided for questions or debriefing regarding the award.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
36C77020Q0637 Rx – Losartan Potassium CMOP National – 7 Facilities RFQ Awarded to:
XLCARE Pharmaceutical Inc.
Note: These are reoccurring Open Market Rx RFQs.
Another RFQ Rx will be post within months.
Individual Award values not posted due to revealing Unit Price info which compromises quote confidentiality – giving unfair competitive advantage to interested parties.
FAR 5.401(a)&(b)(2) Release of Information
Questions or Debrief call or email:
Julian Lake Contract Officer – Level II CMOP Team I
VA National CMOP Contracting 3450 S. 4th Street Leavenworth, KS 66048 Phone: 913-684-0132 Julian.Lake@va.gov
“Delivering Client Centered Acquisition Solutions” “INTEGRITY, COMMITMENT, ADVOCACY, RESPECT, AND EXCELLENCE – these are our goals.” As our client, please take a few moments and let us know how we did by completing the attached SURVEY image1.jpeg image2.jpeg image3.jpeg
File details come from the government source that posted it. Updated .